Alvogen, Inc recalls Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah,…
- Recall date
- December 31, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0259-2026
- FDA classification
- Class II
- Brand / firm
- Alvogen, Inc
- Sold / distributed
- US Nationwide.
Why it was recalled
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Get recall alerts
Free email alert whenever Alvogen, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Alvogen, Inc